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Abstract
FATP1 and FATP4 appear to be important for the cellular uptake and handling of long chain fatty acids (LCFA). These
findings were obtained from loss- or gain of function models. However, reports on FATP1 and FATP4 in human skeletal
muscle are limited. Aerobic training enhances lipid oxidation; however, it is not known whether this involves up-regulation
of FATP1 and FATP4 protein. Therefore, the aim of this project was to investigate FATP1 and FATP4 protein expression in
the vastus lateralis muscle from healthy human individuals and to what extent FATP1 and FATP4 protein expression were
affected by an increased fuel demand induced by exercise training. Eight young healthy males were recruited to the study.
All subjects were non smokers and did not participate in regular physical activity (,1 time per week for the past 6 months,
VO2peak 3.460.1 l O2 min
21). Subjects underwent an 8 week supervised aerobic training program. Training induced an
increase in VO2peak from 3.460.1 to 3.960.1 l min
21 and citrate synthase activity was increased from 53.762.5 to
80.863.7 mmol g
21 min
21. The protein content of FATP4 was increased by 33%, whereas FATP1 protein content was
reduced by 20%. Interestingly, at the end of the training intervention a significant association (r
2=0.74) between the
observed increase in skeletal muscle FATP4 protein expression and lipid oxidation during a 120 min endurance exercise test
was observed. In conclusion, based on the present findings it is suggested that FATP1 and FATP4 proteins perform different
functional roles in handling LCFA in skeletal muscle with FATP4 apparently more important as a lipid transport protein
directing lipids for lipid oxidation.
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Introduction
Skeletal muscle expresses several membrane bound lipid
binding proteins such as the plasma membrane fatty acid binding
protein (FABPpm) [1], fatty acid transport protein (FATP) 1 and 4
[2,3,4,5], fatty acid translocase CD36 (FAT/CD36) [6] and, in
addition, two intracellular proteins, the cytosolic fatty acid binding
protein (FABPc) [7] and the acyl-CoA binding protein (ACBP) [8],
which have been shown to be important in cellular LCFA
handling [9,10,11]. Furthermore, two small integral membrane
proteins, Caveolin 1 and Caveolin 3, critical in the formation of
caveolae in endothelia cells (Caveolin 1) [12] and skeletal muscle
(Caveolin 3) [13], were recently shown to have an important role
in regulation of LCFA metabolism [14,15]. Most of the lipid
binding proteins have been identified in human skeletal muscle on
the protein level [16,17,18,19,20,21]. However, whether protein,
and not only mRNA, levels of FATP1 and FATP4, the major
FATP isoforms expressed in rodent skeletal muscle [3,4,5,22], are
expressed in human skeletal muscle, have yet to be addressed. The
generation of genetic FATP1 and FATP4 loss-of-function models
(i.e. FATP1 KO- and FATP4 heterozygote mice) revealed an
important role in LCFA uptake in muscle cells [23] and
enterocytes [2], respectively. However, the mechanism by which
these proteins facilitate LCFA uptake in skeletal muscle cells is
unclear. Detailed membrane topology analysis suggests that
FATP1 protein has at least one transmembrane and multiple
membrane associated domains [24]. FATP4 appears to share this
transmembrane domain topology [25], and an overall sequence
similarity [26] suggests it is common to all FATP family members
[27]. Importantly, FATP1 and FATP4 were shown to possess long
chain acyl CoA synthetase activity [28,29]. Taken together, the
findings suggest that FATP1 and FATP4 induced activation of
LCFA, by the formation of fatty acyl-CoA once LCFA is taken up
by cells or released from the intramyocellular triacylglycerol
(IMTG) pool, could be a major contributor to the regulation of
LCFA metabolism in skeletal muscle.
Under physiological conditions with increased cellular demand
of LCFA for energy turnover, such as exercise training, FABPpm
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human skeletal muscle [16,19,20,21], whereas reports of the effect
of exercise training on FAT/CD36 protein expression are
contradictory [19,20,21,30]. Furthermore, FABPpm and FAT/
CD36 protein expression were increased in vastus lateralis muscle
from human subjects after 4–7 weeks on an isocaloric high fat diet
[31]. This could indicate that LCFA flux in human skeletal muscle
is associated with an increased FABPpm and FAT/CD36 protein
expression. In contrast, it is unknown how increased LCFA
turnover affects FATP1 and/or FATP4 protein expression.
Therefore the main purpose of this study was to identify if human
skeletal muscle expresses FATP1 and FATP4 at the protein level
and furthermore, whether these proteins were affected by an
increased fuel demand induced by exercise training. We
hypothesized that endurance exercise training, which is known
to increase the potential for an enhanced systemic LCFA
utilization [32,33,34,35] and skeletal muscle lipolytic capacity
[36,37,38,39], will provide adaptations in FATP1 and FATP4
protein expression in order to increase the cellular capacity for FA
handling to accompany the increased cellular LCFA flux.
Methods
Subjects
Eight healthy males (age 3061 yr; body weight 90.065.3 kg;
body fat percentage 30.562.5; body mass index (BMI) 27.062.0)
were recruited to the study (Table 1). These subjects were part of
the individuals included in the study by Nybo et al. [40]. All
subjects were non smokers and did not participate in regular
physical activity (,1 time per week for the past 6 months, VO2peak
3.460.1 l O2 min
21 or 38.261.8 ml O2 min
21 kg
21). Before
volunteering for the study, all subjects were given full oral and
written information about the course of the study and possible risks
associated with participation. Written consent was obtained from
each subject. The study was approved by The Copenhagen Ethics
Committee (KF-01-203/03) and conformed to the code of ethics
of the World medical Association (Declaration of Helsinki II).
Peak oxygen consumption (VO2 peak) was determined by an
incremental exercise test until exhaustion on a Monark Ergomedic
839E bicycle ergometer (Monark, Varberg, Sweden). Expired air
was collected in Douglas bags for later analysis of O2 and CO2
content. Subjects warmed up for 10 min at 100 Watt. Subse-
quently the resistance was increased by 25 Watt every min until
the subject could not maintain the required intensity. The
measured VO2 was accepted as maximal when no further increase
in VO2 in response to an increased work load was obtained and
when the respiratory exchange ratio (RER) was above 1.15. Body
composition was measured using dual-energy X-ray absorptiom-
etry (DEXA, LUNAR DPX IQ RBD, version 4.6b, WI, USA).
On a separate day subjects arrived at the laboratory after an
overnight fast to perform an endurance test on bicycle ergometer.
Exercise consisted of 120 min of bicycle exercise at 60% of each
subject’s individual VO2 peak. During the endurance test oxygen
uptake and RER were frequently determined in order to evaluate the
relative contribution of carbohydrate and lipid for energy turnover
during exercise. Relative substrate utilization was calculated by
following the equations; % Carbohydrate oxidation=((RER-0.7)/
0.3)6100. % Lipidoxidation=100 - % Carbohydrate oxidation [41].
Experimental day
After one day on a controlled standardized diet (65 Energy (E)%
carbohydrate, 20 E% fat and 15 E% protein), subjects arrived in the
morning in the laboratory after an overnight fast (12 h). Subjects
rested for 30 min in the supine position after which blood was
sampled from an arm vein. Thereafter a needle biopsy was obtained,
using a Bergstrom needle with suction, from the vastus lateralis
muscleunder local anesthesia with 2%lidocaine. Themusclesample
was quickly frozen (within 10 seconds) in liquid nitrogen and stored
at 280uC until subsequent biochemical analyses.
Training program
Then subjects initiated an 8 week supervised aerobic training
program. The training was performed on a bicycle ergometer
gradually increasing the training frequency during the 8 weeks.
Each session lasted 40–90 minutes and consisted of intermittent
exercise of varying intensities between 45–80% of VO2 peak. At
three occasions during the training period, maximal oxygen
uptake was measured on a bicycle ergometer and work load in the
training sessions was adjusted accordingly.
At the end of the training period all initial tests were repeated.
The endurance test was performed at the same absolute work load
as pre-training (Table 2). Muscle biopsies were again obtained
from the vastus lateralis muscle 48 h after the last exercise bout.
Diet
During the training period instructions were given not to make
any dietary changes. Initially as well as during the last week of the
training period an individual detailed 3-day food registration was
completed. The subjects weighed and recorded all food and Table 1. Subject characteristics.
Pre Training Post Training
Age, yr 30613 0 61
Height, m 1.8260.02 1.8260.02
Body mass (BM), kg 90.065.3 87.565.8
BMI, kg m
22 27.062.0 26.862.2
Body fat, % 30.562.5 * 27.062.8
Lean body mass (LBM), kg 61.162.3 * 63.162.3
VO2 peak,
lm i n
21 3.460.1 ** 3.960.1
ml kg
21 BM min
21 38.261.8 ** 45.762.0
Data are means 6 SE.
*p,0.05;
**p,0.01 compared with Pre Training, n=8.
doi:10.1371/journal.pone.0029391.t001
Table 2. Exercise performance parameters.
Pre Training Post Training
VO2 (average)
lm i n
21 2.160.1 * 1.960.1
ml kg
21 BM min
21 24.261.7 * 22.461.2
HR (average) 15166 ** 13166
RER (average) 0.9060.03 * 0.8560.01
% Lipid oxidation (average) 32.168.4 * 49.264.4
% CHO oxidation (average) 67.968.4 * 50.864.4
Data are means 6 SE.
*p,0.05;
**p,0.01 compared with Pre Training, n=8.
doi:10.1371/journal.pone.0029391.t002
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macronutrient composition of the diet were calculated (Dankost
2000, Danish Catering Center, Copenhagen, Denmark).
Analyses
Breath samples
Expired volumes of air was collected in Douglas bags and
measured with a chain suspended Collins spirometer. A small
sample of mixed expired air was analyzed for contents of O2
(VacuMed 17518A, Ventura, CA, USA) and CO2 (VacuMed
17515A, Ventura, CA, USA).
Blood and plasma analysis
Blood glucose levels were measured using an ABL 615 analyser
(Radiometer, Copenhagen, Denmark). Plasma long chain fatty
acid (LCFA) concentration (NEFA C kit, Wako Chemicals GmbH,
Neuss, Germany), plasma glycerol and plasma triacylglycerol (TG)
(triacylglycerol GPO-PAP kit) were measured using enzymatic
colorimetric methods (Hitachi 912 automatic analyzer, Mann-
heim, Germany). Plasma TG was calculated as plasma TG minus
free plasma glycerol.
Muscle biopsies
The muscle biopsies were immediately frozen in liquid nitrogen
and stored at 280uC for subsequent biochemical analysis. Before
biochemical analysis the muscle sample was freeze-dried and
dissected free of all visible adipose tissue, connective tissue, and
blood under a stereo microscope (Zeiss, Stemi 2000-C, Oberko-
chen, Germany). The dissected muscle fibers were pooled and
then divided into sub-pools for the respective analyses.
Muscle metabolites
Muscle glycogen concentration was determined as glycosyl units
by a fluorometric method [42] after acid hydrolysis of freeze dried
and dissected muscle tissue. IMTG content was determined by a
biochemical method on dissected and freeze dried tissue as
described previously [43].
Activities of citrate synthase and 3-hydroxy-acyl-CoA
dehydrogenase
Maximal activity of citrate synthase (CS) and 3-hydroxyacyl-
CoA dehydrogenase (HAD) was measured at 25uC in freeze-dried
muscle tissue in accordance to Lowry and Passonneau [44]. CS
was measured on a spectrophotometer (Hitachi 912 Automatic
Analyzer, Roche diagnostics, Hvidovre, Denmark) and HAD by
fluorometry (Ratio-2 filter Fluorometer, Optical Technology
Devices Inc., Bie & Berntsen, Roedovre, Denmark).
Western blot
Muscle proteins were analyzed in total crude membrane (TCM)
and soluble protein (Cytosol) fractions by SDS-PAGE followed by
immunoblotting. In short, muscle biopsies were homogenized at
0uC in a buffer (30 mM Hepes, 40 mM NaCl, 2 mM phenyl-
methylsulphonyl fluoride, 2 mM EGTA, 250 mM sucrose, 5 mM
pepstatin A, 10 mgm L
21 aprotinin) for 20 seconds using a
homogenizer (PT 3100; Brinkmann, Westbury, NY, USA).
Homogenates were separated into a cytosolic (soluble protein
fraction) and a membrane (TCM) fraction by centrifugation at
200.000 g for 1 h at 4uC. The pellet was resuspended (1 mM
EDTA, 50 mM Tris Base, 4% SDS) and centrifuged at 4.000 g for
10 min. Protein content in the two fractions was measured by the
bicinchoninic acid method (Pierce Chemical, Rockford, IL, USA)
using bovine serum albumin as standards. Protein content was
measured in triplicate and a maximal coefficient of variation of 5%
between replicates was accepted. Equal amounts of protein from
TCM and cytosolic fractions were loaded onto appropriate
percentage polyacrylamide selfcasted gels (Bio-Rad, Herlev, Den-
mark) and transferred to polyvinylidene fluoride (PVDF)-mem-
branes (IMMOBILION
TM transfer membranes, Millipore Cor-
poration, Bedford, MA, USA). The membrane was blocked for
1 hour at room temperature with skimmed milk or BSA in Tris-
buffered saline containing 0.1% tween (TBST) and thereafter
incubated overnight at 4uC with a primary antibody followed by
incubation in horseradish peroxidase-conjugated secondary anti-
bodies (DakoCytomation, Copenhagen, Denmark). After antigen-
antibody complexes were visualized using enhanced chemilumi-
nescence (IMMOBILION
TM Western, Millipore Corporation,
Bedford, MA, USA) and quantified using a Kodak Image station
2000MI (Kodak, Glostrup, Denmark) the signal was finally
corrected for between-gel variation relative to a appropriate
standard run on all gels. Preliminary experiments demonstrated
that the amounts of protein loaded were within the dynamic range
for the conditions used and the results obtained (data not shown).
Representative Western blots of proteins in TCM and cytosol
fractions analyzed in the present study are shown in figure 1.
Antibodies
The following commercial antibodies were used: anti-CD36
(R&D Systems, Abingdon, UK), anti-Caveolin 3 (BD transduction
laboratories, San Jose, CA, USA), anti-Caveolin 1 (BD transduction
laboratories, San Jose, CA, USA), anti-b-actin (Sigma-Aldrich,
Copenhagen, Denmark) and b-Tubulin (Sigma-Aldrich, Copenha-
gen, Denmark). The following non-commercial antibodies were
used: anti-FATP4 (raised in rabbits [25]), anti-FATP1 (raised in
rabbits [45]), anti-FABPpm and anti-FABPc (kindly donated by
Prof. Glatz), and anti-ACBP (kindly donated by Dr. Faergeman).
Statistics
Statistical evaluations were performed using SigmaPlot v.11.0
for windows. Data are presented as mean 6 SE. To test for
differences between Pre and Post training samples, the non
parametric Wilcoxon’s signed rank test for paired samples were
performed. The strength of association between parameters was
analyzed by Pearson product moment correlation analysis and
95% confident intervals (CI) for the obtained correlation
coefficients were determined. Differences between samples and
correlations between parameters were considered to be statistically
significant when the p-value was less than 0.05.
Results
Diet
The average macronutrient composition of the diet was 53 E%
carbohydrate, 30 E% fat and 17 E% protein and did not change
during the experimental period (data not shown).
Effects of training on whole body parameters
Body weight averaged 90.065.3 kg prior to exercise training and
was unchanged after the training period (Table 1). In contrast lean
body mass was significantly increased with exercise training from
61.162.3 kg to 63.162.3 kg (p,0.05; Table 1). The exercise
training induced a 15% increase in peak oxygen uptake (VO2 peak)
from 3.460.1 to 3.960.1 l min
21 (p,0.01; Table 1). Initially,
resting blood glucose averaged 5.260.2 mmol l
21, plasma TG
1.860.4 mmol l
21 and plasma LCFA 378658 mmol l
21,a n d
remained unchanged after the training period.
FATP in Human Skeletal Muscle
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Eight weeks of exercise training resulted in a 33% increase in
FATP4 protein expression in skeletal muscle (p,0.01; Figure 2).
In contrast, FATP1 protein expression was reduced by 20%
(p,0.01; Figure 2). FABPpm protein expression was increased
(37%, p,0.01), whereas FAT/CD36 protein expression remained
unchanged after exercise training compared to the pre-exercise
training period (Figure 3). The two cytosolic lipid binding proteins
FABPc and ACBP remained unchanged after exercise training
(Figure 3). In addition, exercise training did not affect protein
levels of Caveolin 1 and Caveolin 3 (Figure 4), suggesting that the
increased potential for LCFA utilization at rest and during
submaximal exercise after exercise training seems not to depend
on an increased skeletal muscle caveolae abundance.
Muscle metabolites and mitochondrial enzymes. Muscle glycogen
content was increased with exercise training from 435646 to
628654 mmol kg
21 d.w. (p,0.05), whereas IMTG content
(104619 vs. 98616 mmol kg
21 d.w.) on an average level,
remained unchanged. Due to the lack of adequate muscle sample
material, only 6 subjects were included in the IMTG analysis. The
maximal activity of CS was increased by 36% (53.762.5 and
80.863.7 mmol g
21 min
21, before and after exercise training,
respectively; p,0.01), and there was a tendency towards an
increase in the maximal activity of HAD (25.861.5 and
30.963.7 mmol g
21 min
21; p=0.078) after the training period.
Correlations
Since endurance exercise training resulted in a shift in substrate
choice towards a higher FA utilization during submaximal exercise
we tested whether the training induced adaptation in lipid binding
protein expression was associated with changes in substrate
utilization during exercise. The training induced adaptation in
skeletal muscle FATP4 protein expression was associated with the
increase in lipid oxidation during the endurance exercise test
(r
2=0.74; p,0.001; CI 0.408#r#0.972, Figure 5). No significant
correlations between the changes in skeletal muscle FABPpm
(r
2=0.18; p=0.3; CI 0.390#r#0.864) or FATP1 (r
2=0.40;
p=0.1; CI -0.118#r#0.922) protein expression and lipid
oxidation during the endurance test were observed.
Discussion
In the present study we demonstrated that FATP1 and FATP4
are expressed in human skeletal muscle on a protein level.
Furthermore, we showed that FATP4 protein content was
increased by 33% in skeletal muscle after 8 weeks of endurance
exercise training compared to pre-training levels. In contrast,
FATP1 protein content was reduced by 20%. Interestingly, the
observed increase in FATP4 protein content was associated with
an increased lipid oxidation during prolonged submaximal
exercise.
Functional studies using primary adipocytes and skeletal muscle
from FATP1 null mice [23] or FATP1 knockdown 3T3-L1
adipocytes [46] have shown that FATP1 only plays a minor role in
basal FA uptake/transport. In contrast, FATP1 was shown to be
required for insulin stimulated LCFA uptake in adipocytes [46,47],
which coincided with an insulin stimulated translocation of FATP1
to the plasma membrane [47]. In addition, FATP1 KO mice
showed a robust reduction in high fat diet induced accumulation
of TG and diacylglycerol (DG) in skeletal muscle [48]. Deletion of
one allele of FATP4 resulted in a 48% reduction in FATP4 protein
Figure 1. Representative images of the proteins analyzed in total crude membranes (TCM) and soluble cytocolic fractions (Cytosol)
from human vastus lateralis muscle are shown. Protein concentration of TCM and cytosol fractions pre- and post training were determined and
equal protein amounts were resolved by SDS-PAGE and membranes were immunoblotted using antibodies specific for FATP1; fatty acid transport
protein 1 (63 kDa) and FATP4; fatty acid transport protein 4 (72 kDa), FAT/CD36; fatty acid translocase CD36 (88 kDa), FABPpm; membrane bound
fatty acid binding protein (43 kDa), FABPc; cytoplasmic fatty acid binding protein (14 kDa), ACBP; acyl-CoA binding protein (10 kDa), and Caveolin 1
(22 kDa), Caveolin 3 (18 kDa). All Western blots were run in parallel with molecular weight markers. Relevant molecular weight markings above and
below each analyzed protein are indicated.
doi:10.1371/journal.pone.0029391.g001
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LCFA (BODIPY) uptake in isolated enterocytes [2]. Milger and
coworkers observed a net increase in LCFA influx when
overexpressing FATP4 in COS cells [25], whereas FATP4
knockdown in adipocytes showed no effect on neither basal nor
insulin stimulated FA uptake [49]. In the latter study it was
suggested that FATP4 may have a functional role in FA re-
esterification following lipolysis [49]. Moreover, in contrast to
FATP1, both Milger et al. (2006) and Lobo et al. (2007) showed
that FATP4 was not localized to the plasma membrane [25,49],
but rather to the endoplasmatic membranes [25], suggesting that
FATP4 may be a key intracellular regulator of LCFA handling.
Adding to the complexity, recent studies have suggested, that in
addition to the importance in LCFA uptake and esterification,
FATP1 may play a novel role in mitochondria [50,51,52]. To this
end, new and interesting findings by Hagberg and coworkers point
towards a key role of the surrounding vasculature in the regulation
of LCFA uptake into peripheral tissue in a FATP3 and FATP4
dependent manner [53]. Thus, regulation of LCFA uptake into
peripheral tissue, such as skeletal muscle, seems to be governed at
multiple sites.
In the present study both FATP1 and FATP4 protein content in
human skeletal muscle were affected by 8 weeks of exercise
training in association with an increase in skeletal muscle oxidative
potential, supported by the finding of an increased activity in
mitochondrial key enzymes. Surprisingly, FATP1 and FATP4
Figure 2. Divergent effects of exercise training on membrane bound lipid binding protein expression in human skeletal muscle.
Protein concentration of total crude membrane (TCM) fractions before and after 8 weeks of exercise training were determined and equal protein
amounts were resolved by SDS-PAGE and membranes were immunoblotted using antibodies specific for FATP1, FATP4, FAT/CD36 and FABPpm. b-
actin was run on membranes as control and was unchanged with exercise training. Eight weeks of endurance exercise training resulted in reduced
FATP1 protein expression in skeletal muscle (A). In contrast, (B) FATP4 and (C) FABPpm protein expression was increased after the training
intervention compared to before training. FAT/CD36 protein expression was similar before and after training (D). Representative Western blots of
protein levels before (Pre) and after the exercise training period (Post) from the same subjects are shown (E). Black bars represents pre training values
and grey bars represents post training values. **; p,0.01.
doi:10.1371/journal.pone.0029391.g002
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endurance exercise training did not affect (A) FABPc or (B) ACBP protein levels in human skeletal muscle. Protein concentration of cytosol fractions
pre- and post training were determined and equal protein amounts were resolved by SDS-PAGE and membranes were immunoblotted using
antibodies specific for FABPc and ACBP. b-tubulin was run on membranes as control and was unchanged with exercise training. Representative
Western blots of protein levels before (Pre) and after the exercise training period (Post) from the same subjects are shown (C). Black bars represents
pre training values and grey bars represents post training values.
doi:10.1371/journal.pone.0029391.g003
Figure 4. The Caveolae proteins Caveolin1 and Caveolin 3 were unaffected by exercise training. Eight weeks of endurance exercise
training did not affect (A) Caveolin 1 and (B) Caveolin 3 protein levels. Protein concentration of TCM fractions pre- and post training were determined
and equal protein amounts were resolved by SDS-PAGE and membranes were immunoblotted using antibodies specific for Caveolin 1 and Caveolin
3. b-actin was run on membranes as control and was unchanged with exercise training. Representative Western blots of protein levels before (Pre)
and after the exercise training period (Post) from the same subjects are shown (C). Black bars represents pre training values and grey bars represents
post training values.
doi:10.1371/journal.pone.0029391.g004
FATP in Human Skeletal Muscle
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skeletal muscle (Figure 2). This could suggest that these two
proteins have different roles in the cellular handling of LCFA in
human skeletal muscle, which is in line with findings in some cell
models [49]. Interestingly, we observed an association between the
increase in FATP4, but not FATP1, protein expression in skeletal
muscle and the oxidation of LCFA (estimated from RER) during a
submaximal exercise bout (Figure 5). This suggests a role of
FATP4 in skeletal muscle LCFA oxidation during exercise.
Importantly, these associations are based on a low number of
subjects and should thus be interpreted with caution. Findings
from FATP1 KO mice have shown a robust reduction in TG and
DG accumulation in skeletal muscle when consuming a high fat
diet [48], and thus the role of FATP1 could be to handle LCFA
taken up into the myocyte. In contrast to FATP1 protein it seems
that FATP4 protein plays a role in intracellular LCFA trafficking.
This suggestion is supported by the findings from the present study
of a positive association between FATP4 protein level and lipid
oxidation during exercise and by the findings by Lobo and
coworkers [49], who showed that FATP4 may function in LCFA
re-esterification following lipolysis in adipocytes. Therefore, one
could speculate that in human skeletal muscle FATP4 is important
in handling LCFA released from lipid droplets by directing them
either to re-esterification into the lipid droplets or oxidation in
mitochondria, whereas, the role of FATP1 could be handling
LCFA taken up into the myocyte. Furthermore, earlier studies on
FATP proteins have demonstrated, that these proteins shared
considerable sequence homologies and domain organization with
acyl-CoA-synthethase, suggesting that FATP proteins are mem-
bers of the super-family of adenylate forming acyl-CoA
synthethases (ACS), which are responsible for the formation of
the fatty acyl-CoA esters from LCFA that are needed for LCFA to
be metabolized [4,8,54,55]. Taken together, the observations
made in the present study supports differential functions for
FATP1 and FATP4 proteins in regulation of LCFA handling in
human skeletal muscle, likely by acylation of incoming LCFA and
LCFA generated from IMTG lipolysis, and directing these to
metabolism or esterification. The distribution of FATP1 and
FATP4 between different muscle fibers is unknown in human
skeletal muscle. It is unlikely that the applied training regime will
induced a shift from type 2 fibers to type 1 fibers in humans [56],
and thus we do not believe this is a contributing factor in the
differential adaptation in FATP1 and FATP4 protein expression.
However, it should be noted that a training induced shift within
type 2 fibers (i.e. from type 26to type 2A) could have occurred. If
this in some way affects FATP1 and/or FATP4 protein expression
warrants further study. In the present design the subjects were
examined before and after 8 weeks of exercise training. Due to the
lack of a non exercising control group we cannot rule out that
external factors other than exercise training and diet could have
influenced our findings. Therefore, the present findings should be
corroborated in a longitudinal study including a non-exercising
control group. On the other hand, different adaptations of several
of the measured proteins to the 8 week intervention period were
observed supporting that the present findings occurred as a
consequence of exercise training.
In the present study endurance exercise training induced an
increase in FABPpm protein content. This is consistent with
several findings in the literature of increased FABPpm protein
expression in vastus lateralis muscle with different types of exercise
training [16,19,20,21]. In contrast, findings from studies where the
effect of exercise training on skeletal muscle FAT/CD36 protein
expression have been investigated in humans are contradictory
[19,20,21,30]. In the present study FAT/CD36 protein levels in
the vastus lateralis muscle remained unchanged after 8 weeks of
endurance training compared to pre training levels in male human
subjects (Figure 2). These findings are in agreement with some
previous studies [19,20], but not all [21,30]. In a cross sectional
study, comparing trained and untrained male and female subjects,
Kiens et al. (2004) similar protein levels of FAT/CD36 in vastus
Figure 5. Association between lipid oxidation and exercise training induced adaptations in FATP4 protein expression in human
skeletal muscle. Eight weeks of endurance exercise training resulted in a shift in substrate choice towards a higher FA utilization during
submaximal exercise. This training induced adaptation was associated with the observed increase in FATP4 protein expression.
doi:10.1371/journal.pone.0029391.g005
FATP in Human Skeletal Muscle
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groups, despite the markedly higher oxidative capacity in the
trained subjects [19]. In contrast, Tunstall et al. (2002) reported
that 9 days of endurance exercise training induced an increase in
FAT/CD36 protein expression by ,20% in skeletal muscle of 3
men and 4 women [30]. Importantly, 90 min of submaximal
bicycle exercise (60% of VO2 peak) induced an immediate
increase in FAT/CD36 mRNA in vastus lateralis muscle from
both untrained and trained males and females [19]. Furthermore,
24 hours after a single bout of glycogen depleting exercise FAT/
CD36 protein expression was significantly elevated in male
subjects [57]. Therefore, the increase in FAT/CD36 protein
expression by Tunstall et al. (2002) could be ascribed to the effect
of the last exercise bout rather than a training effect, because the
muscle biopsy in that study was obtained only 24 hours after the
last exercise bout [30]. Spriet and co-workers recently observed
that FAT/CD36 protein content was either unchanged or
increased by ,10% in vastus lateralis muscle after 2 and 6 weeks
of high intensity interval bicycle exercise training (10 bouts of
4 min at .90% VO2max followed by 2 min rest) [20,21]. The
reason for the discrepancy in findings by the latter studies applying
similar protocols is unclear. It is however interesting to note that
FAT/CD36 protein content have only been shown to increase
when short term high intensity exercise training was performed
[21,30] and not when more aerobically endurance exercise
training, as in the present study, was applied [19]. The up-
regulation of FAT/CD36 protein seen in some human studies
[21,30] and also in some rat studies, using 7 days of chronic low
frequency stimulation of the peroneal nerve [58,59], could be an
early adaptation in FAT/CD36 protein levels, whereas long-term
endurance exercise training gradually would return the FAT/
CD36 protein content to the initial levels, possible after other
adaptations in skeletal muscle metabolism have occurred. The
observed differences could also potentially be the result of the
different type of exercise (endurance vs. high intense exercise) or
subject recruitment criteria, such as pre-training oxygen uptake
and body composition.
In summary, in the present study we showed an up-regulation of
FATP4 protein expression in human skeletal muscle after 8 weeks
of endurance training. The increase in FATP4 protein was
associated with an increased lipid oxidation during prolonged
submaximal exercise after the training intervention. This possible
interaction between FATP4 and lipid oxidation should be
corroborated in a study using a larger cohort of subjects including
a non-exercise control group. In contrast, the endurance exercise
training intervention was followed by a decrease in FATP1 protein
expression. Taken together, it is demonstrated that both FATP1
and FATP4 proteins are present in skeletal muscle and the data
suggest that FATP1 and FATP4 proteins could have different roles
in handling fatty acids within human skeletal muscle.
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